Singapore market cap down 3% in November, as Omicron infects investor sentiment

THE total value of Singapore stocks was weighed down in November by fears of the more infectious and vaccine-resistant Omicron Covid-19 variant, which derailed hopes of a sustained recovery after snapping a 3-month losing streak in the previous month.


See also  Saudi Arabia in talks to provide COVID-19 vaccines to Yemen

Leave a Reply